UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026257
Receipt number R000030100
Scientific Title The effect of intravenous acetaminophen on postoperative pain control after esophageal cancer surgery, a prospective randomized study.
Date of disclosure of the study information 2017/04/01
Last modified on 2019/03/01 16:25:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of intravenous acetaminophen on postoperative pain control after esophageal cancer surgery, a prospective randomized study.

Acronym

The effect of intravenous acetaminophen on postoperative pain control after esophageal cancer surgery, a prospective randomized study.

Scientific Title

The effect of intravenous acetaminophen on postoperative pain control after esophageal cancer surgery, a prospective randomized study.

Scientific Title:Acronym

The effect of intravenous acetaminophen on postoperative pain control after esophageal cancer surgery, a prospective randomized study.

Region

Japan


Condition

Condition

Esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To prove the efficacy of intravenous acetamonophen on postoperative pain control after esophageal cancer surgery compared with epidural anesthesia alone.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase III


Assessment

Primary outcomes

The frequency of analgesic rescue dose

Key secondary outcomes

Side effect of opioid
Pain(until 7 days after surgery)
The days until first gait, flatus, and constipation after surgery
Hospital stay days after surgery


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Using asetaminophen until 7days after surgery.
4 times per a day, 15mg/kg
Combination with epidural anesthesia

Interventions/Control_2

Not using asetaminophen.
Only epidural anesthesia

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

a person older than 20 years old
sex dose not matter
a person who was informed sufficiently, and agree to participate this study of one's free will

Key exclusion criteria

A person who had contraindication about treatment below,
1,Epidural analgesia
2,using acetaminophen
3,using NSAIDs

A person who do not agree to participate this study and was unsuitable for this study

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Tangoku

Organization

Tokushima university and graduated school,

Division name

Thoracic, endocrine oncology and surgery

Zip code


Address

18-15, Kuramotocho,Tokushima,Japan

TEL

088-633-7173

Email

tangoku@tokushima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takeshi Nishino

Organization

Tokushima university and graduated school

Division name

Thoracic, endocrine oncology and surgery

Zip code


Address

18-15, Kuramotocho,Tokushima,Japan

TEL

088-633-7173

Homepage URL


Email

nishinotakeshi@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima university

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 03 Month 31 Day

Date of IRB


Anticipated trial start date

2017 Year 04 Month 01 Day

Last follow-up date

2019 Year 03 Month 17 Day

Date of closure to data entry

2019 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded

2019 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 02 Month 21 Day

Last modified on

2019 Year 03 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030100


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name